Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
AVITA Medical develops and commercializes advanced acute wound care solutions centered on its patented RECELL technology, which creates autologous skin cell suspensions to accelerate healing of burns, full-thickness skin defects, and vitiligo. The company’s product portfolio includes RECELL devices and complementary wound care matrices like PermeaDerm and Cohealyx. Serving burn and trauma centers primarily in the U.S. and select international markets, AVITA leverages proprietary technology, regulatory approvals, and clinical evidence to improve patient outcomes and reduce treatment costs.
This description was generated via AI from an annual report. Updated about 1 year ago.